C.R. Bard introduced its Recovery IVC filter in 2003, marketing it as a retrievable temporary device. Post-market studies quickly revealed alarmingly high fracture rates — struts breaking off the filter body and traveling through the bloodstream to the heart, lungs, and other organs. Bard's internal communications, now part of the MDL discovery record, show that company engineers and executives knew about the fracture risk years before the FDA acted. Rather than disclosing the defect or issuing a recall, Bard transitioned to the G2 model — which shared the same fundamental design flaw — without notifying implanting physicians or patients.
Bard's IVC filter product line includes the Recovery, G2, G2X (also called G2 Express), Eclipse, Meridian, and Denali filters. The Recovery and G2 models carry the highest documented fracture rates and command the highest settlement values in the MDL program. If you had any of these Bard filter models, you may be eligible for compensation through the global settlement framework now administered by the MDL Plaintiffs' Steering Committee.
Becton, Dickinson and Company acquired C.R. Bard in 2017 for approximately $24 billion and assumed all IVC filter product liabilities. As a publicly traded company with significant reputational and financial exposure, BD reached a confidential global settlement framework with plaintiffs' leadership approximately in 2022 to 2023. Most remaining Bard MDL cases are now resolving under a tiered settlement grid. New cases are still being accepted into the settlement program — contact our attorneys today to begin the enrollment process.
Frequently Asked Questions
Related Pages
IVC filter complications range from asymptomatic strut fracture to life-threatening cardiac perforation and pulmonary embolism. Because many fractures are discovered incidentally on imaging, patients may not know their filter has failed. If you have an IVC filter and have not had recent imaging, see a doctor and call us.
Learn moreCook Medical manufactured the Günther Tulip and Celect IVC filters. Studies documented high rates of caval penetration with the Celect model. Cook MDL 2570 is in the Southern District of Indiana. Unlike Bard, Cook has not reached a global settlement — your case may go to trial. The Hill v. Cook $460,000 verdict is the benchmark.
Learn moreThe most important evidence is imaging confirming filter fracture or strut migration (CT scan, X-ray, or fluoroscopy), your device implant record showing the filter model and lot number, and any treatment records for filter-related complications. You do not need to gather this yourself — our attorneys will request your records directly.
Learn moreThe FDA warned in 2010 and again in 2014 that retrievable IVC filters posed serious risks when left in place long-term. Post-market 522 studies ordered in 2015 to 2016 confirmed high fracture and perforation rates. No recall was ever issued — but FDA warnings are powerful evidence of manufacturer knowledge in IVC filter lawsuits.
Learn moreMost states allow 2 years from the date you discovered — or should have discovered — your IVC filter failed. MDL registration in Bard MDL 2641 or Cook MDL 2570 tolls your individual state statute of limitations. Florida's SOL dropped from 4 years to 2 years in 2023. Do not wait: call today for a free statute of limitations analysis.
Learn moreRetrievable IVC filters were designed to be temporary, but many became permanently embedded — struts penetrating vessel walls or the heart, making standard retrieval impossible. High-risk open or hybrid surgical removal is itself a serious injury and a compensable claim. Even if your filter was never removed, fractured struts remaining in place support a lawsuit.
Learn moreBard MDL 2641 (D. Ariz.): global settlement program active; most cases resolving under tiered grid; new cases still enrolling. Cook MDL 2570 (S.D. Ind.): no global settlement; approximately 1,000 to 2,000 cases remain unresolved; individual case management orders active. State court clusters active in California, Texas, New Jersey, and New York for Cook cases outside the MDL.
Learn moreYou may qualify if you had a Bard or Cook IVC filter and experienced fracture, strut migration, cardiac or organ perforation, pulmonary embolism attributable to filter failure, or a difficult or impossible retrieval procedure. Even if you have no symptoms, imaging showing strut fracture or migration may support a claim. Contact us for a free evaluation.
Learn moreNo IVC filter has ever been formally recalled. The FDA issued safety communications in 2010 and 2014 urging filter retrieval, and ordered post-market 522 studies that confirmed high fracture and perforation rates. The absence of a recall does not mean the devices were safe — the MDL discovery record establishes decades of concealed defect data.
Learn moreBard's global settlement program uses a tiered grid: minor fracture cases start around $25,000 to $100,000; fractures requiring surgical removal reach $150,000 to $400,000; cardiac perforation and death cases may exceed $400,000 to $750,000. Cook has no global settlement — values depend on individual case strength and trial risk. Bellwether verdicts anchor valuations: Hyde $3.6M, Tinlin $1.59M, Hill (Cook) $460K.
Learn moreIVC filter fractures are frequently asymptomatic. Warning signs include unexplained back or abdominal pain, chest pain, heart palpitations, and shortness of breath. The only definitive test is imaging. If you have an IVC filter and have not had recent follow-up CT or X-ray, request imaging from your doctor and call us for a free consultation.
Learn moreIVC Filter Lawsuit
Retrievable IVC filters manufactured by C.R. Bard and Cook Medical have failed at alarming rates — fracturing, migrating to the heart, and perforating organs. Two federal MDLs are actively resolving thousands of claims. Bard has entered a confidential global settlement program; Cook cases proceed individually. Free consultations available.
View full case overview